实用皮肤病学杂志
實用皮膚病學雜誌
실용피부병학잡지
JOURNAL OF PRACTRCAL DERMATOLOGY
2015年
2期
126-128
,共3页
安彩霞%向芳%杨珊%普雄明
安綵霞%嚮芳%楊珊%普雄明
안채하%향방%양산%보웅명
氨甲环酸%激光,Q开关Nd∶YAG%黄褐斑
氨甲環痠%激光,Q開關Nd∶YAG%黃褐斑
안갑배산%격광,Q개관Nd∶YAG%황갈반
Tranexamic acid%Q-Switched Nd:YAG laser%Melasma
目的:研究口服氨甲环酸联合Q开关Nd∶YAG激光治疗黄褐斑的临床疗效和安全性。方法57例黄褐斑患者随机分为试验组和对照组,试验组在接受Nd∶YAG激光治疗的同时口服氨甲环酸片12周,对照组仅接受Nd∶YAG激光治疗。治疗后4、8、12周对患者进行黄褐斑皮损面积和严重度指数(MASI)评分,观察临床治疗效果并记录不良反应。结果随着治疗时间增加,患者的MASI评分逐渐下降。治疗后8周、12周,试验组和对照组患者MASI评分比较差异有统计学意义(P<0.05)。两组患者无明显不良反应发生。结论 Q开关Nd∶YAG激光联合氨甲环酸口服治疗黄褐斑安全有效,且不良反应少。
目的:研究口服氨甲環痠聯閤Q開關Nd∶YAG激光治療黃褐斑的臨床療效和安全性。方法57例黃褐斑患者隨機分為試驗組和對照組,試驗組在接受Nd∶YAG激光治療的同時口服氨甲環痠片12週,對照組僅接受Nd∶YAG激光治療。治療後4、8、12週對患者進行黃褐斑皮損麵積和嚴重度指數(MASI)評分,觀察臨床治療效果併記錄不良反應。結果隨著治療時間增加,患者的MASI評分逐漸下降。治療後8週、12週,試驗組和對照組患者MASI評分比較差異有統計學意義(P<0.05)。兩組患者無明顯不良反應髮生。結論 Q開關Nd∶YAG激光聯閤氨甲環痠口服治療黃褐斑安全有效,且不良反應少。
목적:연구구복안갑배산연합Q개관Nd∶YAG격광치료황갈반적림상료효화안전성。방법57례황갈반환자수궤분위시험조화대조조,시험조재접수Nd∶YAG격광치료적동시구복안갑배산편12주,대조조부접수Nd∶YAG격광치료。치료후4、8、12주대환자진행황갈반피손면적화엄중도지수(MASI)평분,관찰림상치료효과병기록불량반응。결과수착치료시간증가,환자적MASI평분축점하강。치료후8주、12주,시험조화대조조환자MASI평분비교차이유통계학의의(P<0.05)。량조환자무명현불량반응발생。결론 Q개관Nd∶YAG격광연합안갑배산구복치료황갈반안전유효,차불량반응소。
ObjectiveTo evaluate the efficacy and safety of oral tranexamic acid (TA) combined with low-fluence 1064nm Q-switched Nd:YAG laser in the treatment of melasma. MethodsFifty-seven patients with melasma were enrolled in the study and randomly divided into two groups: a combination group and a laser treatment group. All the patients were treated with low-lfuence Nd:YAG laser, meanwhile TA was taken orally by the patients in the combination group lasted for 12 weeks. The degree of improvement in pigmentation was reassessed on 4, 8 and 12 weeks after treatment by melasma area severity index (MASI) scores. Side-effects, if any, were also recorded.ResultsThe MASI scores were decreased with the process of the treatment. Two groups showed signiifcant difference on 8 and 12 weeks after treatment (P<0.05). No serious adverse effects had been found.ConclusionOral TA in combination with low-lfuence Nd:YAG laser may be a safe and efifcient treatment option for melasma.